PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Carrington Laboratories

Press Release


Receive press releases from Carrington Laboratories: By Email RSS Feeds:

Carrington Laboratories and Racing Legend Johnny Rutherford Sign Endorsement and Personal Agreement


Irving, TX, February 17, 2007 --(PR.com)-- Carrington Laboratories, Inc. (Nasdaq: CARN) announced it has entered into a one-year endorsement and personal services agreement with racing legend Johnny Rutherford. The partnership provides a platform for Carrington to reach the rapidly growing and attractive racing enthusiast consumer market.

Under the terms of the agreement, Carrington will develop, market and sell a line of personal care products, targeted at racing enthusiasts, under the Johnny Rutherford Tuff-Skin® brand. The products will be prominently displayed and promoted on Carrington’s new corporate website. In addition to the products, the website will include the biography, statistics and other useful information on Johnny Rutherford. Mr. Rutherford’s book Lone Star J.R., the Autobiography of Racing Legend Johnny Rutherford will be available on the website. Additionally, racing fans will receive a free JR Tuff-Skin t-shirt with every purchase through Carrington’s newly designed website.

"This is a great opportunity for Carrington to reach a highly desirable demographic and further diversify the markets that Carrington serves," stated Ms. Pamela Schonbeck, Carrington’s Senior Sales and Marketing Director for Consumer Services. "Johnny has a large and loyal race fan base and we are truly excited about tapping into it and having our company associated with him."

The JR Tuff-Skin® line of products includes a hand cleaner, a burn and cut gel and a hand guard to protect and revitalize skin. A new sunscreen will soon be added to the product line. All products are produced at Carrington facilities in Texas. The facilities are ISO certified and produce products under Current Good Manufacturing Practices (cGMP) as recognized by the FDA.

About Johnny Rutherford
Johnny Rutherford, also known to racing fans as "Lone Star JR", began racing in 1959. During his highly successful career, Mr. Rutherford was the National Sprint Car Champion in 1965 and became a household name with his first Indianapolis 500 mile race win in 1974. He followed that win with victories at Indy in 1976 and 1980. In addition to his Indianapolis 500 win in 1980, Mr. Rutherford also won the US Auto Club Championship and was CART champion. In 1987 Johnny Rutherford was inducted into the Indianapolis Motor Speedway Hall of Fame. He is also a member of the International Motor Sports Hall of Fame, Motor Sports Hall of Fame of America, National Sprint Car Hall of Fame, and Texas Sports Hall of Fame. Today, Johnny Rutherford is the special events director of the Indy Racing League (IRL). Among his duties, Mr. Rutherford drives the pace car at all the IRL events and enjoys working with the rookie drivers.

About Carrington
Carrington Laboratories, Inc., is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol® and cosmetic raw material Hydrapol™. Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington raw materials from Aloe vera L. are the only raw materials from the plant with the DSHEA claim of enhancing the immune system.

Carrington’s wholly-owned subsidiary, DelSite Biotechnologies, Inc. is developing its proprietary GelSite® technology designed to provide controlled release of peptide and protein-based drugs. DelSite is currently developing a nasal powder vaccine using its GelVac™ formula with the H5N1 avian flu antigen. This work is partially funded by two grants from the Department of Health and Human Services.

Carrington and DelSite technologies are protected by more than 130 patents in 26 countries. Select products carry the CE mark, recognized worldwide. For more information, visit www.carringtonlabs.com.

Certain statements in this release concerning Carrington may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to: subsequent changes in plans by the Company’s management; delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company’s filings with the Securities & Exchange Commission, including the Form 10-Q, filed November 14, 2006.

###
Contact Information
Pharmaceutical Contract Manufacturing
Doug Golwas
(800) 527-5216
Contact
www.carringtonlabs.com/

Click here to view the list of recent Press Releases from Carrington Laboratories
Promote Your Business